Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · IEX Real-Time Price · USD

2.130

-0.090 (-4.05%)

At close: Apr 19, 2024, 4:00 PM

2.080

-0.050 (-2.35%)

After-hours: Apr 19, 2024, 7:19 PM EDT

Regulus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Net Income	-30.04	-28.32	-27.81	-15.73	-18.59	-48.71	-71.91	-81.84	-55.75	-56.68	Upgrade
Depreciation & Amortization	0.23	0.12	0.46	0.47	0.93	2.26	2.52	2.28	1.59	1.49	Upgrade
Share-Based Compensation	2.8	2.18	2.92	2.61	2.29	5.44	7.64	12.87	15.37	7.04	Upgrade
Other Operating Activities	0.24	0.5	0.3	0.11	-4.45	-2.27	2.97	9.81	-11.07	8.64	Upgrade
Operating Cash Flow	-26.77	-25.53	-24.13	-12.54	-19.82	-43.27	-58.77	-56.88	-49.86	-39.51	Upgrade
Capital Expenditures	-0.61	-0.36	-0.25	0	0.1	-0.02	-0.3	-0.91	-1.36	-1.15	Upgrade
Change in Investments	15.1	-14.76	0	0	0	46.54	14.26	36.28	22.91	-28	Upgrade
Other Investing Activities	-	-	-	-0.01	-0.02	-	-0.02	-0.05	-0.07	-0.07	Upgrade
Investing Cash Flow	14.49	-15.12	-0.25	-0.01	0.07	46.52	13.94	35.31	21.48	-29.21	Upgrade
Share Issuance / Repurchase	15.12	4.49	53.82	19.13	42.17	0.22	43.42	0.95	7.17	88.38	Upgrade
Debt Issued / Paid	-3.3	0	-0.08	-9.62	-2.24	-3.05	0	19.6	-0.16	-0.14	Upgrade
Financing Cash Flow	11.82	4.49	53.74	9.51	39.93	-2.83	43.42	20.55	7.02	88.24	Upgrade
Net Cash Flow	-0.46	-36.16	29.36	-3.03	20.19	0.42	-1.42	-1.02	-21.37	19.52	Upgrade
Free Cash Flow	-27.38	-25.89	-24.38	-12.54	-19.72	-43.3	-59.08	-57.8	-51.22	-40.66	Upgrade
Free Cash Flow Margin	-	-	-	-125.28%	-288.70%	-60131.94%	-82050.00%	-4840.45%	-246.75%	-530.13%	Upgrade
Free Cash Flow Per Share	-1.44	-1.70	-2.85	-3.58	-11.43	-49.66	-94.22	-131.30	-119.56	-110.65	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).